Werewolf Therapeutics, Inc.
HOWL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001785530
In the last 90 days, Werewolf Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 45 institutions reported holding it in 13F filings for Q2 2026, worth $3.91M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Werewolf Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 51
- +9 vs. Q3 2021
- Shares held
- 19.1M
- +132.8K (+0.7%) vs. Q3 2021
- Total value
- $228.3M
- −$98.0M (−30.0%) vs. Q3 2021
- New holders
- 12
- 21 more added
- Sold out
- 3
- 7 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HOWL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 45 | $3.91M |
| Q1 2026 | 48 | $11.7M |
| Q4 2025 | 51 | $9.34M |
| Q3 2025 | 62 | $41.6M |
| Q2 2025 | 65 | $24.3M |
| Q1 2025 | 70 | $26.7M |
| Q4 2024 | 73 | $41.7M |
| Q3 2024 | 69 | $68.3M |
| Q2 2024 | 71 | $79.3M |
| Q1 2024 | 61 | $209.7M |
| Q4 2023 | 41 | $106.8M |
| Q3 2023 | 35 | $51.1M |
| Q2 2023 | 36 | $73.3M |
| Q1 2023 | 38 | $62.5M |
| Q4 2022 | 39 | $42.8M |
| Q3 2022 | 44 | $94.5M |
| Q2 2022 | 46 | $78.0M |
| Q1 2022 | 49 | $84.3M |
| Q4 2021 | 51 | $228.4M |
| Q3 2021 | 42 | $326.2M |
| Q2 2021 | 45 | $344.3M |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Werewolf Therapeutics, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 4,291,881 | $51.1M | 0.90% | 00.0% | Unchanged |
| MPM Asset Management LLC | 4,284,172 | $51.0M | 11.03% | 00.0% | Unchanged |
| MPM Oncology Impact Management LP | 2,388,011 | $28.4M | 5.18% | 00.0% | Unchanged |
| BlackRock Inc. | 1,276,208 | $15.2M | 0.00% | +906,247+245.0% | Added |
| Adage Capital Partners GP, L.L.C. | 960,448 | $11.4M | 0.02% | −25,000−2.5% | Reduced |
| Deerfield Management Company, L.P. (Series C) | 958,125 | $11.4M | 0.24% | −794,662−45.3% | Reduced |
| Sphera Funds Management Ltd. | 648,391 | $7.72M | 0.92% | −40,084−5.8% | Reduced |
| DC Funds, LP | 580,902 | $6.92M | 40.97% | −8,200−1.4% | Reduced |
| Vanguard Group Inc | 527,545 | $6.28M | 0.00% | +357,280+209.8% | Added |
| Avidity Partners Management LP | 485,000 | $5.78M | 0.12% | −140,120−22.4% | Reduced |
| PFM Health Sciences, LP | 400,000 | $4.76M | 0.17% | 00.0% | Unchanged |
| FMR LLC | 370,734 | $4.42M | 0.00% | +132,234+55.4% | Added |
| State Street Corp | 259,626 | $3.09M | 0.00% | +143,562+123.7% | Added |
| Geode Capital Management, LLC | 214,224 | $2.55M | 0.00% | +77,752+57.0% | Added |
| Platinum Investment Management Ltd | 213,381 | $2.54M | 0.07% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 206,201 | $2.46M | 0.03% | 00.0% | Unchanged |
| Northern Trust Corp | 200,065 | $2.38M | 0.00% | +129,661+184.2% | Added |
| Migdal Insurance & Financial Holdings Ltd. | 187,500 | $2.23M | 0.02% | 00.0% | Unchanged |
| Caas Capital Management LP | 162,599 | $1.94M | 0.18% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 64,783 | $772.0K | 0.00% | +34,994+117.5% | Added |
| Soleus Capital Management, L.P. | 64,585 | $769.0K | 0.10% | −498,811−88.5% | Reduced |
| Nuveen Asset Management, LLC | 36,879 | $731.0K | 0.00% | +16,916+84.7% | Added |
| Charles Schwab Investment Management Inc | 60,594 | $722.0K | 0.00% | +41,172+212.0% | Added |
| Bank of America Corp | 28,265 | $337.0K | 0.00% | +27,646+4,466.2% | Added |
| JPMorgan Chase & Co | 28,057 | $334.0K | 0.00% | +24,209+629.1% | Added |
| Two Sigma Investments, LP | 22,034 | $262.0K | 0.00% | +22,034 | New |
| Evercore Wealth Management, LLC | 21,500 | $256.0K | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 19,305 | $230.0K | 0.00% | +19,305 | New |
| Deutsche Bank AG | 16,047 | $191.0K | 0.00% | +11,696+268.8% | Added |
| Granite Point Capital Management, L.P. | 15,000 | $179.0K | 0.07% | +15,000 | New |
| California State Teachers Retirement System | 14,434 | $172.0K | 0.00% | +10,392+257.1% | Added |
| American International Group, Inc. | 14,034 | $167.0K | 0.00% | +9,891+238.7% | Added |
| New York State Common Retirement Fund | 13,864 | $165.0K | 0.00% | −901−6.1% | Reduced |
| Manufacturers Life Insurance Company, The | 12,831 | $153.0K | 0.00% | +12,831 | New |
| Wells Fargo & Company | 12,699 | $151.0K | 0.00% | +12,699 | New |
| Susquehanna International Group, LLP | 11,829 | $141.0K | 0.00% | +11,829 | New |
| MetLife Investment Management | 11,421 | $136.0K | 0.00% | +11,421 | New |
| Goldman Sachs Group Inc | 10,080 | $120.0K | 0.00% | +10,080 | New |
| UBS Group AG | 9,459 | $113.0K | 0.00% | +7,820+477.1% | Added |
| Metropolitan Life Insurance Co | 8,460 | $100.8K | 0.00% | +8,460 | New |
| Morgan Stanley | 8,063 | $96.0K | 0.00% | +6,549+432.6% | Added |
| Citigroup Inc | 7,920 | $94.0K | 0.00% | +7,053+813.5% | Added |
| Royal Bank of Canada | 5,680 | $68.0K | 0.00% | +4,884+613.6% | Added |
| Legal & General Group Plc | 2,492 | $30.0K | 0.00% | +1,756+238.6% | Added |
| Ameritas Investment Partners, Inc. | 2,041 | $24.0K | 0.00% | +1,448+244.2% | Added |
| STRS Ohio | 1,800 | $21.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 652 | $8.00K | 0.00% | +234+56.0% | Added |
| High Net Worth Advisory Group LLC | 500 | $6.00K | 0.00% | +500 | New |
| Financial Perspectives, Inc | 250 | $2.98K | 0.00% | 00.0% | Unchanged |
| Daiwa Securities Group Inc. | 80 | $1.00K | 0.00% | +80 | New |
| Confluence Wealth Services, Inc. | 100 | $1.00K | 0.00% | +100 | New |
| Nicholas Investment Partners, LP | 0 | $0 | 0.00% | −296,283−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −125,873−100.0% | Sold out |
| Levin Capital Strategies, L.P. | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |